Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Maxamine histamine dihydrochloride: Phase II

Interim results of MMP's 129-patient international Phase II study showed that the combination of Maxamine plus interferon-alpha produced a

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE